Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-058868
Filing Date
2008-03-17
Accepted
2008-03-17 16:20:09
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 779506
2 FIRST AMENDMENT TO LEASE AGREEMENT dex102.htm EX-10.2 8890
3 FORM OF INCENTIVE STOCK OPTION AGREEMENT dex108.htm EX-10.8 22111
4 FORM OF NON-QUALIFIED STOCK OPTION AGREEMENT dex109.htm EX-10.9 20388
5 SECOND AMENDMENT TO PATENT SECURITY AGREEMENT dex1033.htm EX-10.33 16028
6 CONSENT OF GRANT THORNTON LLP dex231.htm EX-23.1 2076
7 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 8961
8 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9056
9 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 2821
10 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 2842
  Complete submission text file 0001193125-08-058868.txt   874088
Mailing Address 110 LITTLE FALLS RD FAIRFIELD NJ 07004-2193
Business Address 110 LITTLE FALLS RD FAIRFIELD NJ 07004-2193 9738820860
UNIGENE LABORATORIES INC (Filer) CIK: 0000352747 (see all company filings)

EIN.: 222328609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16005 | Film No.: 08693188
SIC: 2833 Medicinal Chemicals & Botanical Products